Headlines

Enfusion vs investment bankers in a deep talk

Enfusion (ENFN.N), a U.S. software provider for asset managers, is exploring options, including a possible sale, as it engages with investment bankers, according to sources familiar with the situation. The Chicago-based company, valued at $1.1 billion, began interviewing investment banks recently after attracting interest from potential buyers, including private equity firms, with sources requesting anonymity…

Read More